At a glance
- Originator Yamanouchi
- Developer Mercian; Yamanouchi
- Class Antibacterials; Macrolides
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.